Ureaplasma vs Mycoplasma: Key Differences in Symptoms, Testing, and Treatment

Ureaplasma and mycoplasma are closely related bacteria from the same family, but they are different organisms with different clinical implications. The key distinction: Mycoplasma genitalium is almost always considered pathogenic when detected, while ureaplasma is frequently a harmless commensal that only sometimes causes disease. This difference fundamentally changes how each positive test result should be interpreted and treated.

If your lab report mentions ureaplasma, mycoplasma, or both, the natural first question is whether these are the same thing — and whether you should be concerned. The short answer is that they are related but distinct, and the clinical significance of each depends on the specific species detected and whether you have symptoms.

How Are Ureaplasma and Mycoplasma Related?

Both organisms belong to the class Mollicutes and the family Mycoplasmataceae. They share a defining biological feature: neither has a cell wall. This characteristic makes them naturally resistant to beta-lactam antibiotics (penicillin, amoxicillin, cephalosporins) and invisible on Gram stain — two factors that contribute to underdiagnosis in clinical settings.

Beyond this family resemblance, the clinically relevant species diverge significantly:

Ureaplasma species — Ureaplasma urealyticum and Ureaplasma parvum. Both are common urogenital commensals. U. urealyticum is associated with urethritis, cervicitis, and adverse pregnancy outcomes. U. parvum is generally considered a harmless colonizer.

Mycoplasma species — Mycoplasma genitalium is the primary pathogen of concern. It causes urethritis in men, cervicitis in women, and is increasingly recognized as a significant STI. Mycoplasma hominis is less commonly pathogenic but can cause bacterial vaginosis-associated infections and postpartum complications.

Which Is More Serious?

Mycoplasma genitalium is generally considered the more clinically significant infection for several reasons:

• More consistently pathogenic — while ureaplasma is found in up to 70% of sexually active adults as a commensal, M. genitalium is present in only 1-6% of the general population and is more strongly associated with disease when detected

• Higher rates of antibiotic resistance — macrolide resistance in M. genitalium exceeds 50% in many populations globally, making treatment significantly more challenging than ureaplasma

• Stronger link to pelvic inflammatory disease (PID) — M. genitalium has been convincingly linked to PID and tubal factor infertility, with evidence approaching the strength of chlamydia's association

• CDC recognition — the CDC STI Treatment Guidelines include specific diagnostic and treatment recommendations for M. genitalium, while ureaplasma is mentioned primarily in the context of non-gonococcal urethritis without specific screening recommendations

That said, ureaplasma should not be dismissed. When U. urealyticum causes symptomatic urethritis, cervicitis, or pregnancy complications, it requires the same clinical attention as any other sexually transmitted pathogen. For a comprehensive overview, see our ureaplasma guide and mycoplasma genitalium guide.

How Do Symptoms Compare?

The symptoms of ureaplasma and M. genitalium infection overlap substantially — which is part of what makes differential diagnosis challenging:

Shared symptoms: urethral discharge, burning during urination, cervicitis, pelvic pain, and pain during intercourse. Both can be completely asymptomatic.

Key differences in presentation:

• M. genitalium is more likely to cause persistent or recurrent urethritis that fails initial treatment — particularly if azithromycin was used first-line (due to high macrolide resistance rates)

• Ureaplasma symptoms tend to be milder and more subtle when present

• M. genitalium has a stronger documented association with PID and ectopic pregnancy risk in women

• Ureaplasma has a stronger documented association with adverse pregnancy outcomes (preterm birth, premature rupture of membranes)

Testing: One Test or Two?

Ureaplasma and mycoplasma require separate, specific tests. Neither is detected by standard chlamydia/gonorrhea panels. The testing landscape:

• Multiplex PCR panels — some laboratories offer panels that test for both ureaplasma species and M. genitalium simultaneously from a single urine or swab sample. This is the most efficient approach when both organisms are suspected.

• Individual PCR tests — ureaplasma-specific and M. genitalium-specific tests are also available separately.

• Resistance testing — for M. genitalium, macrolide resistance mutation testing is increasingly recommended before choosing antibiotics. This is not yet standard for ureaplasma due to its lower resistance rates.

If you are being tested for one, it often makes sense to test for both — particularly in cases of recurrent urethritis or cervicitis where the cause remains unclear after standard STD testing.

Treatment: Where the Differences Matter Most

Treatment approaches for ureaplasma and M. genitalium differ significantly, and using the wrong protocol is a common cause of treatment failure:

Ureaplasma treatment:

• First-line: Doxycycline 100 mg twice daily for 7 days

• Alternative: Azithromycin 1 g single dose

• Resistant cases: Moxifloxacin

• Treatment success rate with doxycycline: >90%

M. genitalium treatment (per CDC guidelines):

• Preferred: Doxycycline 100 mg twice daily for 7 days, followed by resistance-guided therapy (azithromycin if macrolide-susceptible, moxifloxacin if macrolide-resistant)

• A single 1 g dose of azithromycin should NOT be used for M. genitalium due to high macrolide resistance rates

• Treatment is more complex and may require sequential antibiotics

The critical takeaway: doxycycline alone often cures ureaplasma but is less effective as monotherapy for M. genitalium. If you have a co-infection with both organisms, the M. genitalium treatment protocol should take priority, as it is the more difficult infection to clear. For detailed treatment information, see our ureaplasma treatment guide.

Can You Have Both at the Same Time?

Yes. Co-infection with ureaplasma and M. genitalium (or M. hominis) is documented and can complicate treatment. Because both organisms inhabit the same urogenital environment and share the same transmission route, dual infection is not uncommon — particularly in individuals with multiple sexual partners or those presenting to STI clinics.

When co-infection is detected, the treatment approach should address the more resistant organism first. In practice, this usually means following the M. genitalium treatment protocol, which will often clear ureaplasma simultaneously (since doxycycline is the initial step in both treatment algorithms).

When to Seek Urgent Care

• Persistent urethritis after two antibiotic courses — may indicate M. genitalium with macrolide resistance, requiring specialist referral and resistance-guided therapy

• Pelvic pain with fever in women — possible PID, which both organisms can contribute to, requiring urgent evaluation

• Co-infection confirmed — treatment may need to be sequential or combined, warranting infectious disease or sexual health specialist input

Frequently Asked Questions

Is ureaplasma the same as mycoplasma?

No. They belong to the same bacterial family and share key characteristics (no cell wall, sexually transmitted), but they are different organisms. Mycoplasma genitalium is more consistently pathogenic and harder to treat. Ureaplasma is more often a harmless commensal that occasionally causes disease.

Can you have both ureaplasma and mycoplasma?

Yes. Co-infection is documented and not uncommon, since both organisms share the same transmission route and urogenital environment. When both are detected, treatment should prioritize the M. genitalium protocol, as it addresses the more treatment-resistant infection.

Which is more serious, ureaplasma or mycoplasma?

Mycoplasma genitalium is generally considered more clinically significant due to its stronger association with PID, its higher rates of antibiotic resistance, and its more consistent pathogenicity. However, ureaplasma can cause significant problems during pregnancy and may impair fertility.

Are ureaplasma and mycoplasma STDs?

Both are primarily sexually transmitted. M. genitalium is increasingly recognized as a true STD by public health authorities. Ureaplasma occupies a gray zone — it is sexually transmitted but often exists as a harmless commensal, so a positive test does not necessarily indicate active infection.

The Bottom Line

Ureaplasma and mycoplasma are related but clinically distinct. If your test results mention either or both, the most important step is understanding which specific species was detected, whether you have symptoms, and what the appropriate treatment protocol is for your situation. Getting the diagnosis right matters — because the wrong antibiotic for the wrong organism is a recipe for treatment failure. If you need testing that covers both organisms, comprehensive STD testing with specific ureaplasma and mycoplasma panels is the most thorough approach.